Suvorexant-Induced Dream Enactment Behavior in Parkinson Disease: A Case Report

Suvorexant is a new insomnia drug, and it is generally safe and well tolerated. Here, we report a rare but potentially important adverse effect of suvorexant in a patient with Parkinson disease.

Citation:

Tabata H, Kuriyama A, Yamao F, Kitaguchi H, Shindo K. Suvorexant-induced dream enactment behavior in Parkinson disease: a case report. J Clin Sleep Med. 2017;13(5):759–760.

http://ift.tt/2r2uFlS